Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influenza Vaccine Elicited Immune Response in Immunocompromised Patients

NCT06738082 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.

NCT NCT06738082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06738082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influenza Vaccine Elicited Immune Response in Immunocompromised Patients
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Phase
Observational
Overall status
Completed
Start date
October 15, 2024
Completion date
January 31, 2025
Enrollment
147 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunocompromised patients, influenza vaccine